Unlocking Recovery: Sublocade and Counseling Integration

Unlocking Recovery: Sublocade and Counseling Integration

When you adopt Sublocade and counseling integration, you benefit from a long-acting medication combined with structured psychosocial support for opioid use disorder. By pairing once-monthly buprenorphine injections with evidence-based therapy, you can maintain stable medication levels and address the emotional, behavioral, and social factors that drive addiction. At Carolina Energetics, you can explore a full suite of long-acting injectable addiction treatments, including Sublocade for opioid maintenance and Vivitrol for relapse prevention.

In this article, you will learn:

  • How Sublocade works and its monthly administration schedule
  • The role of Vivitrol in relapse prevention
  • Key advantages of long-acting injections
  • Strategies for integrating counseling with medication-assisted treatment
  • A comparison of injectable options
  • Guidance on insurance coverage and provider selection
  • Practical steps to start your recovery journey

Sublocade treatment overview

Sublocade is an extended-release injectable form of buprenorphine designed to suppress withdrawal symptoms and cravings for 28 days. Once administered, it delivers a steady dose of medication, reducing the highs and lows associated with daily dosing. Since its FDA approval, over 350,000 people have been prescribed Sublocade between March 1, 2018 and February 7, 2025 [1].

Mechanism of action

  • Buprenorphine is a partial opioid agonist that binds tightly to mu-receptors
  • It blocks full opioid agonists, reducing the risk of overdose
  • Stable receptor occupancy helps prevent cravings without producing euphoria

Administration schedule

  1. First injection: administered in the abdomen, buttock, thigh, or upper arm
  2. Rapid induction option: a second shot can be given as early as 1 week and up to 1 month after the first to build therapeutic levels quickly [2]
  3. Monthly maintenance: subsequent injections occur every 28 days, ensuring uninterrupted coverage

Vivitrol program overview

Vivitrol is a once-monthly injection of naltrexone, an opioid antagonist approved for preventing relapse in alcohol and opioid use disorders. By blocking opioid receptors, Vivitrol diminishes cravings and the rewarding effects of opioids. You must complete a detoxification period before the first injection to avoid precipitated withdrawal. At Carolina Energetics, our vivitrol program outpatient clinic integrates monthly injections with a comprehensive relapse prevention plan, emphasizing both medication management and behavioral support.

Benefits of monthly injections

Long-acting injectables like Sublocade and Vivitrol offer several advantages over daily oral medications:

  • Consistent medication levels: steady receptor occupancy reduces withdrawal risk
  • Improved adherence: once-a-month dosing lowers the chance of missed doses
  • Enhanced privacy: fewer pharmacy visits and reduced stigma
  • Lower overdose risk: stable partial agonist levels (for Sublocade) help prevent overdose peaks
  • Focus on therapy: you can concentrate on counseling and life skills instead of pill management

Learn more about our monthly Sublocade treatment program to see if this option aligns with your recovery goals.

Counseling integration strategies

Medication-assisted treatment is most effective when combined with counseling and psychosocial support. Integrating therapy helps you develop coping skills, address underlying issues, and build a supportive network.

Evidence-based therapies

  • Cognitive behavioral therapy (CBT): identifies and replaces negative thought patterns
  • Motivational interviewing: enhances your readiness and commitment to change
  • Contingency management: uses incentives to reinforce positive behaviors

In a clinical study, patients receiving Sublocade plus counseling were 14 times more likely to maintain abstinence than those on placebo plus counseling—28 percent success versus 2 percent [3]. This demonstrates the impact of pairing medication with professional guidance.

Outpatient and telehealth support

Carolina Energetics offers flexible counseling options to fit your schedule:

  • In-person individual and group sessions
  • Telehealth follow-up visits for convenience
  • Family therapy and peer support groups

Our sublocade-medication-management-support team works with you to create an individualized plan that integrates monthly injections and ongoing counseling.

Compare injectable options

When choosing between Sublocade and Vivitrol, consider how each aligns with your history, clinical needs, and lifestyle.

Feature Sublocade Vivitrol
Active agent Buprenorphine (partial agonist) Naltrexone (antagonist)
Dosing frequency Monthly Monthly
Withdrawal precipitation Low when induction protocols are followed High if opioids remain in the system
Euphoria potential None None
Ideal use Moderate to severe opioid dependence Relapse prevention in opioid or alcohol use
Privacy benefits Reduced daily pharmacy visits Reduced daily pharmacy visits
Typical setting Outpatient MAT clinic Outpatient vivitrol maintenance therapy
Program integration monthly-sublocade-treatment-program vivitrol program outpatient clinic

Overall, Sublocade and Vivitrol each play a distinct role in long-acting injectable addiction treatment. Your clinical team can help you weigh these factors based on your unique situation.

Insurance and coverage

Access to injectable MAT depends on insurance verification, in-network benefits, and possible prior authorization.

Verifying insurance

  • Check your policy for medication-assisted treatment coverage
  • Utilize our sublocade-insurance-verification-support to confirm benefits
  • Explore Medicaid options, including covered Sublocade appointments [4]

Coverage options

  • Private insurance: many major carriers cover Sublocade and Vivitrol
  • AHCCCS and BCBS: both provide in-network injectable MAT benefits
  • Self-pay: we offer transparent pricing if insurance is not available

For details on alcohol relapse prevention, review our substance use vivitrol program coverage information and insurance-covered-vivitrol-injection guidelines.

Selecting treatment provider

Choosing the right clinic ensures you receive coordinated care for both medication and counseling.

Finding local clinics

Assessing program fit

Consider these factors when evaluating centers:

Starting your recovery journey

Embarking on a monthly injectable program involves clear, step-by-step planning:

  1. Initial consultation: review your medical history and recovery goals
  2. Insurance verification: confirm coverage with our support team
  3. Induction phase: complete any required detox or buprenorphine test dosing
  4. First injection: schedule at your chosen clinic or via telehealth setup
  5. Counseling appointments: begin individual or group therapy sessions
  6. Ongoing maintenance: receive monthly injections and adjust therapy as needed

By following these steps and leveraging our sublocade recovery program with insurance, you create a balanced, supportive environment conducive to lasting change.

Take the next step toward sustained recovery by contacting Carolina Energetics today. Our team is ready to guide you through medication management, counseling integration, and insurance support—providing the individualized plan you need to thrive.

References

  1. (Sublocade)
  2. (Sublocade)
  3. (Recovery In Motion)
  4. (sublocade-appointment-covered-by-medicaid)

Start Your Healing Journey with Carolina Energetics PC

Ready to begin your path to recovery? Contact us now to schedule a consultation and experience the difference of personalized, professional care in a welcoming environment.

Office Hours
Blood Testing Hours
Urine Testing Hours

Save Buprenorphine

Buprenorphine is under threat—and so are the patients who depend on it.

This life-saving medication is now listed as a “suspicious drug,” leading many pharmacies to stop dispensing it altogether. The DEA is pushing for everyone to switch to Buprenorphine/Naloxone (Suboxone), but not every patient can tolerate Naloxone. Many experience severe side effects or have legitimate sensitivity—even when allergy tests fail to detect it.

We’ve seen firsthand the damage this policy shift is causing.

We need your voice. Congressmen Paul Tonko and Senator Martin Heinrich are sponsoring a bill to protect access to Buprenorphine, and bipartisan support is growing. We urge you to contact your state Senators and President Trump online to support this bill. Your advocacy could help restore patient choice and save lives.

Don’t let politics get in the way of proper care. Help us protect access to Buprenorphine.